Discontinuation report GLUCAGON
| Report ID | 257931 |
| Drug Identification Number | 02243297 |
| Brand name | GLUCAGON |
| Common or Proper name | asdf |
| Company Name | ELI LILLY CANADA INC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | GLUCAGON |
| Strength(s) | 1MG |
| Dosage form(s) | POWDER FOR SOLUTION KIT |
| Route of administration | SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR |
| Packaging size | asdf |
| ATC code | H04AA |
| ATC description | GLYCOGENOLYTIC HORMONES |
| Reason for discontinuation | Raw material availability |
| Anticipated discontinuation date | 2027-03-03 |
| Actual discontinuation date | |
| Remaining supply date | |
| Discontinuation status | To be discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | Yes |
| Contact Address | EXCHANGE TOWER, 130 KING STREET WEST TORONTO, ONTARIO CANADA M5X 1B1 |
| Company contact information | Lilly Canada’s Customer Response Centre 1-888-545-5972. |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v3 | 2026-01-05 | English | Compare |
| v2 | 2026-01-05 | French | Compare |
| v1 | 2026-01-05 | English | Compare |
Showing 1 to 3 of 3